Personalized mRNA Cancer Vaccine Shows Promise in Late-Stage Melanoma Trial A personalized cancer treatment using the same messenger RNA technology that transformed vaccine development during the COVID-19 pandemic has delivered encouraging results in a large late-stage trial of melanoma....
